Compugen Ltd(NASDAQ:CGEN) 
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody...
Website: http://www.cgen.com
Founded: 1981
Full Time Employees: 61
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.35
H 1.37
L 1.28
C 1.31
V 393,769
10EMA 1.31
20EMA 1.31
60EMA 1.31
120EMA 1.31
250EMA 1.31